In medical device manufacturing, the required production environment should follow the component's risk profile, handling path, and specifications. The key question is which environment matches the component's intended use, contamination sensitivity, end-use requirements, and controls the failure modes that matter for the part.
The decision between ISO Class 7 cleanroom molding and general molding should be tied to end use, contamination sensitivity, downstream handling, and validation requirements. In this article, we'll breakdown where ISO 7 cleanroom molding is usually justified, where general molding remains appropriate, and what engineering inputs should drive the specification.
Two injection molded parts can share similar geometry and resin requirements while needing very different manufacturing environments. A housing used onan external monitoring device does not present the same contamination pathway as a molded connector that enters a fluid path. Their manufacturing environment requirements, however, are fundamentally different.
That difference matters because contamination risk is not defined by molding alone. It is defined by what happens to the part after ejection, how the part is handled, where it is assembled, and whether particulate or bioburden cold affect performance or patient safety.
Matching the cleanroom classification to the component's actual exposure pathway ensures you invest in environmental controls where they produce a measurable safety benefit. This distinction is vital for producing high quality medical components without overloading your program budget.
Changing a manufacturing environment mid-program is expensive. If a project launches in general molding and later requires ISO 7 conditions, the molder will likely need to revalidate the process, transfer tooling to a different press cell, and repeat IQ/OQ/PQ protocols.
Defining contamination risk during the design phase, ideally during design for manufacturing (DFM) review, prevents these disruptions. Your risk assessment should account for the device classification, patient contact pathway, and any customer or regulatory specifications that mandate a controlled environment.
An ISO 7 cleanroom, defined by ISO 14644-1, limits airborne particle concentrations to specific thresholds per cubic meter:
These limits are maintained through HEPA filtration, positive air pressure, controlled personnel gowning, and restricted material introduction. In molding, that matters most when a part remains vulnerable to particulate deposition during the molding process, ejection, open handling, assembly, or packaging.
ISO 7 classification addresses airborne particulate. It does not replace or duplicate process quality standards such as ISO 13485, which governs the broader quality management system for medical devices. A manufacturer can hold ISO 13485 certification and operate both cleanroom and general molding facilities.
This distinction separates two different questions: "Is the manufacturer's quality system robust?" and "Does this specific component need a particle-controlled molding environment?" The answer to the first should always be yes. The answer to the second depends on the part's end-use risk profile.
Cleanroom injection molding is typically appropriate when particulate introduced during molding or immedicate post-mold handling could affect device safety, function, or downstream validation. Examples include:
In these cases, post-mold cleaning alone may not be sufficient to meet bioburden targets. Controlling the environment during molding and assembly reduces the contamination load before sterilization. This gives you a wider process margin and helps ensure your validated bioburden limits hold consistently across production runs.
Some OEMs and end-market regulations specify cleanroom manufacturing outright. Class III devices under FDA 21 CFR Part 820, for instance, carry documentation and environmental control expectations that align with ISO 7 conditions. Similarly, pharmaceutical customers may flow down cleanroom requirements to molded components that enter a sterile fill-finish line.
When a specification explicitly calls for ISO 7, the decision is already made. At that point, the engineering task is ensuring your manufacturing partner can demonstrate third-party cleanroom certification, validated processes, and documented traceability within that controlled environment.
External housings, structural brackets, non-patient-contact enclosures, and device components that undergo downstream cleaning often do not require a particle-controlled molding environment. Specifying ISO 7 for these parts adds overhead to the per-part cost through gowning protocols, environmental monitoring, and ongoing maintenance of the cleanroom infrastructure.
General molding, performed in a well-maintained production environment under ISO 13485 controls, delivers the dimensional precision and material performance these components need without the incremental cost of cleanroom operation.
Some programs specify cleanroom conditions only at the assembly or packaging stage, not at the molding stage. If molded parts will be cleaned, sterilized, and then assembled in a controlled environment before reaching the patient, the molding step itself may not need ISO 7 conditions.
This is a program-level engineering decision. The key question is where in your manufacturing workflow contamination control produces the greatest risk reduction.
Before writing ISO 7 into a molding specification, work through these questions with your engineering and quality teams:
If the answer to the first three questions is no and the answer to the fourth is yes, general molding deserves serious consideration. If any of the first three is yes, ISO 7 is likely the appropriate specification.
A defensible specification ties the manufacturing environment to documented risk analysis. Include the following in your program documentation:
This documentation protects the program during audits and provides a clear record if the specification is ever challenged by a customer or regulatory body.
Crescent Industries manufactures injection-molded components in both general production and ISO 7 cleanroom environments, all within a vertically integrated, U.S.-based facility. Our ISO 13485-certified quality management system applies across both environments, so process controls, inspection, lot traceability and downstream support are consistent regardless of the cleanroom classification.
For programs that require ISO 7 cleanroom injection molding, Crescent provides third-party certified ISO 7 cleanroom, validated molding processes, and cleanroom assembly and packaging services. For components where general molding is the right fit, we deliver the same engineering support, DFM collaboration, and process development without the added cleanroom overhead.
If you're defining the manufacturing environment for a medical component, start the conversation early. Crescent Industries supports both ISO 7 cleanroom molding and general molding along with building tools that run in either of these facilities along with ISO 13485 certified quality systems, process development, quality validations and protocols. Contact us to discuss your component requirements.
ISO 7 permits a maximum of 352,000 particles per cubic meter at 0.5 microns, while ISO 8 permits 3,520,000 at the same particle size. ISO 7 is typically required for higher-risk medical components, while ISO 8 is often sufficient for pharmaceutical packaging and lower-risk devices.
No. Many medical components, particularly external housings and non-patient-contact parts, can be molded in a general production environment under ISO 13485 controls. Crescent Industries supports both general molding and ISO 7 cleanroom molding when those environments are specified for the program.
Cleanroom molding carries higher overhead due to HEPA filtration, gowning requirements, environmental monitoring, and restricted material handling. These costs are justified when the component's end use demands particle control. For parts that do not require it, general molding avoids that incremental overhead.
Involve your manufacturing partner during the quote phase. Early discussions help align tooling, validation, handling, and assembly plans with the specification already defined for the program. Crescent Industries supports both general molding and ISO 7 cleanroom molding, so we can manufacture to the environment your component requires.